203 related articles for article (PubMed ID: 23569258)
1. Overcoming drug-resistant herpes simplex virus (HSV) infection by a humanized antibody.
Krawczyk A; Arndt MA; Grosse-Hovest L; Weichert W; Giebel B; Dittmer U; Hengel H; Jäger D; Schneweis KE; Eis-Hübinger AM; Roggendorf M; Krauss J
Proc Natl Acad Sci U S A; 2013 Apr; 110(17):6760-5. PubMed ID: 23569258
[TBL] [Abstract][Full Text] [Related]
2. Prevention of herpes simplex virus induced stromal keratitis by a glycoprotein B-specific monoclonal antibody.
Krawczyk A; Dirks M; Kasper M; Buch A; Dittmer U; Giebel B; Wildschütz L; Busch M; Goergens A; Schneweis KE; Eis-Hübinger AM; Sodeik B; Heiligenhaus A; Roggendorf M; Bauer D
PLoS One; 2015; 10(1):e0116800. PubMed ID: 25587898
[TBL] [Abstract][Full Text] [Related]
3. A novel glycoprotein D-specific monoclonal antibody neutralizes herpes simplex virus.
Du R; Wang L; Xu H; Wang Z; Zhang T; Wang M; Ning Y; Deng F; Hu Z; Wang H; Li Y
Antiviral Res; 2017 Nov; 147():131-141. PubMed ID: 29061442
[TBL] [Abstract][Full Text] [Related]
4. Impact of valency of a glycoprotein B-specific monoclonal antibody on neutralization of herpes simplex virus.
Krawczyk A; Krauss J; Eis-Hübinger AM; Däumer MP; Schwarzenbacher R; Dittmer U; Schneweis KE; Jäger D; Roggendorf M; Arndt MA
J Virol; 2011 Feb; 85(4):1793-803. PubMed ID: 21123390
[TBL] [Abstract][Full Text] [Related]
5. Antibody-based immunotherapy of aciclovir resistant ocular herpes simplex virus infections.
Bauer D; Keller J; Alt M; Schubert A; Aufderhorst UW; Palapys V; Kasper M; Heilingloh CS; Dittmer U; Laffer B; Eis-Hübinger AM; Verjans GM; Heiligenhaus A; Roggendorf M; Krawczyk A
Virology; 2017 Dec; 512():194-200. PubMed ID: 28985573
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a type-common human recombinant monoclonal antibody to herpes simplex virus with high therapeutic potential.
De Logu A; Williamson RA; Rozenshteyn R; Ramiro-Ibañez F; Simpson CD; Burton DR; Sanna PP
J Clin Microbiol; 1998 Nov; 36(11):3198-204. PubMed ID: 9774565
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of the epitope for a herpes simplex virus glycoprotein B-specific monoclonal antibody with high protective capacity.
Däumer MP; Schneider B; Giesen DM; Aziz S; Kaiser R; Kupfer B; Schneweis KE; Schneider-Mergener J; Reineke U; Matz B; Eis-Hübinger AM
Med Microbiol Immunol; 2011 May; 200(2):85-97. PubMed ID: 20931340
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
[TBL] [Abstract][Full Text] [Related]
9. Development of a highly effective combination monoclonal antibody therapy against Herpes simplex virus.
Seyfizadeh N; Kalbermatter D; Imhof T; Ries M; Müller C; Jenner L; Blumenschein E; Yendrzheyevskiy A; Grün F; Moog K; Eckert D; Engel R; Diebolder P; Chami M; Krauss J; Schaller T; Arndt M
J Biomed Sci; 2024 May; 31(1):56. PubMed ID: 38807208
[TBL] [Abstract][Full Text] [Related]
10. A new promising candidate to overcome drug resistant herpes simplex virus infections.
Zinser E; Krawczyk A; Mühl-Zürbes P; Aufderhorst U; Draßner C; Stich L; Zaja M; Strobl S; Steinkasserer A; Heilingloh CS
Antiviral Res; 2018 Jan; 149():202-210. PubMed ID: 29155164
[TBL] [Abstract][Full Text] [Related]
11. Herpes Simplex Virus Type 2 Is More Difficult to Neutralize by Antibodies Than Herpes Simplex Virus Type 1.
Silke Heilingloh C; Lull C; Kleiser E; Alt M; Schipper L; Witzke O; Trilling M; Eis-Hübinger AM; Dittmer U; Krawczyk A
Vaccines (Basel); 2020 Aug; 8(3):. PubMed ID: 32867086
[TBL] [Abstract][Full Text] [Related]
12. Antiviral activities of human monoclonal antibodies to herpes simplex virus.
Fujinaga S; Sugano T; Matsumoto Y; Masuho Y; Mori R
J Infect Dis; 1987 Jan; 155(1):45-53. PubMed ID: 3025308
[TBL] [Abstract][Full Text] [Related]
13. Successful foscarnet therapy for acyclovir-resistant mucocutaneous infection with herpes simplex virus in a recipient of allogeneic BMT.
Verdonck LF; Cornelissen JJ; Smit J; Lepoutre J; de Gast GC; Dekker AW; Rozenberg-Arska M
Bone Marrow Transplant; 1993 Feb; 11(2):177-9. PubMed ID: 8382096
[TBL] [Abstract][Full Text] [Related]
14. Cell-to-Cell Spread Blocking Activity Is Extremely Limited in the Sera of Herpes Simplex Virus 1 (HSV-1)- and HSV-2-Infected Subjects.
Criscuolo E; Castelli M; Diotti RA; Amato V; Burioni R; Clementi M; Ambrosi A; Mancini N; Clementi N
J Virol; 2019 Jun; 93(11):. PubMed ID: 30867302
[TBL] [Abstract][Full Text] [Related]
15. Resistance of herpes simplex virus infections to nucleoside analogues in HIV-infected patients.
Levin MJ; Bacon TH; Leary JJ
Clin Infect Dis; 2004 Nov; 39 Suppl 5():S248-57. PubMed ID: 15494896
[TBL] [Abstract][Full Text] [Related]
16. A Therapeutic Antiviral Antibody Inhibits the Anterograde Directed Neuron-to-Cell Spread of Herpes Simplex Virus and Protects against Ocular Disease.
Bauer D; Alt M; Dirks M; Buch A; Heilingloh CS; Dittmer U; Giebel B; Görgens A; Palapys V; Kasper M; Eis-Hübinger AM; Sodeik B; Heiligenhaus A; Roggendorf M; Krawczyk A
Front Microbiol; 2017; 8():2115. PubMed ID: 29163407
[TBL] [Abstract][Full Text] [Related]
17. Protection against zosteriform spread of herpes simplex virus by monoclonal antibodies.
Mester JC; Glorioso JC; Rouse BT
J Infect Dis; 1991 Feb; 163(2):263-9. PubMed ID: 1846388
[TBL] [Abstract][Full Text] [Related]
18. Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity.
Kohl S; Loo LS
J Immunol; 1982 Jul; 129(1):370-6. PubMed ID: 6282968
[TBL] [Abstract][Full Text] [Related]
19. Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization.
Stránská R; Schuurman R; Nienhuis E; Goedegebuure IW; Polman M; Weel JF; Wertheim-Van Dillen PM; Berkhout RJ; van Loon AM
J Clin Virol; 2005 Jan; 32(1):7-18. PubMed ID: 15572000
[TBL] [Abstract][Full Text] [Related]
20. Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease.
Dix RD; Pereira L; Baringer JR
Infect Immun; 1981 Oct; 34(1):192-9. PubMed ID: 6271681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
